|
EP1712226A3
(en)
*
|
1996-04-05 |
2007-03-21 |
The General Hospital Corporation |
Treatment of a Hemoglobinopathy
|
|
US6315995B1
(en)
*
|
1996-09-27 |
2001-11-13 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating an ischemic disorder and improving stroke outcome
|
|
US8128963B2
(en)
|
1996-09-27 |
2012-03-06 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating ischemic disorders using carbon monoxide
|
|
ATE355029T1
(de)
*
|
1998-04-01 |
2006-03-15 |
Univ Columbia |
Verfahren zur thrombosehemmung bei patienten deren blut extrakorporaler zirkulation ausgesetzt ist
|
|
US7678390B2
(en)
|
1999-04-01 |
2010-03-16 |
Yale University |
Carbon monoxide as a biomarker and therapeutic agent
|
|
FR2816212A1
(fr)
*
|
2000-11-03 |
2002-05-10 |
Air Liquide Sante Int |
Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
|
|
US20030198639A1
(en)
*
|
2002-04-16 |
2003-10-23 |
Frenette Paul S. |
Methods of treating sickle cell disease
|
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
|
MXPA03012031A
(es)
*
|
2001-06-21 |
2005-07-01 |
Univ Yale |
El monoxido de carbono mejoraresultados en transplantes de tejido y organo y suprime apoptosis.
|
|
US6472390B1
(en)
*
|
2001-11-13 |
2002-10-29 |
Duke University |
Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
|
|
NZ534912A
(en)
|
2002-02-04 |
2007-08-31 |
Alfama Investigacao E Desenvol |
supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative
|
|
BRPI0307673A2
(pt)
|
2002-02-13 |
2016-11-08 |
Beth Israel Hospital |
métodos de tratar doença vascular.
|
|
WO2003088748A1
(en)
|
2002-04-15 |
2003-10-30 |
Beth Israel Deaconess Medical Center |
Use of heme oxygenase-1 and products of heme degradation
|
|
EP1499328B1
(en)
|
2002-04-15 |
2015-09-16 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Methods of treating necrotizing enterocolitis
|
|
RS91004A
(sr)
|
2002-04-15 |
2007-02-05 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education, |
Postupci za lečenje ileusa
|
|
JP4549847B2
(ja)
*
|
2002-05-17 |
2010-09-22 |
イエール ユニバーシティ |
肝炎の治療方法
|
|
DE10230165A1
(de)
|
2002-07-04 |
2004-01-15 |
Ino Therapeutics Gmbh |
Verfahren und Vorrichtung zur Administration von Kohlenmonoxid
|
|
PL377733A1
(pl)
*
|
2002-11-07 |
2006-02-06 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Leczenie wstrząsu krwotocznego
|
|
CN1901795B
(zh)
|
2003-10-22 |
2014-03-26 |
弗雷德哈钦森癌症研究中心 |
用于在细胞，组织，器官，和有机体中诱导停滞的方法，组合物和装置
|
|
EP1552840A1
(en)
*
|
2004-01-07 |
2005-07-13 |
Aga Ab |
Use of a xenon/carbon monoxide mixture for the protection of cells
|
|
PL2264043T3
(pl)
|
2005-09-02 |
2018-04-30 |
Glycomimetics, Inc. |
Heterobifunkcyjne inhibitory pan-selektyny
|
|
WO2009126556A1
(en)
|
2008-04-08 |
2009-10-15 |
Glycomimetics, Inc. |
Pan-selectin inhibitor with enhanced pharmacokinetic activity
|
|
EP2356224A4
(en)
*
|
2008-11-10 |
2012-12-26 |
Sinai School Medicine |
METHOD OF INHIBITING WEB TREATMENT IN CONNECTION WITH INFLAMMATION THROUGH NEUTROPHILACTIVITY INHIBITION
|
|
CN101732348B
(zh)
*
|
2008-11-11 |
2015-01-14 |
威世药业（如皋）有限公司 |
牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途
|
|
US8921328B2
(en)
|
2010-09-14 |
2014-12-30 |
Glycomimetics, Inc. |
E-selectin antagonists
|
|
EP2699242B1
(en)
|
2011-04-19 |
2017-11-01 |
Alfama, Inc. |
Carbon monoxide releasing molecules and uses thereof
|
|
JP6134710B2
(ja)
|
2011-07-21 |
2017-05-24 |
アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． |
一酸化ルテニウム放出分子およびその使用
|
|
KR102055958B1
(ko)
|
2011-12-22 |
2019-12-13 |
글리코미메틱스, 인크. |
E-셀렉틴 길항제 화합물, 조성물, 및 이용 방법
|
|
JP5967631B2
(ja)
*
|
2012-04-27 |
2016-08-10 |
学校法人日本大学 |
上皮及び内皮損傷の治療剤
|
|
US9867841B2
(en)
|
2012-12-07 |
2018-01-16 |
Glycomimetics, Inc. |
Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells
|
|
JP6689854B2
(ja)
|
2014-12-03 |
2020-04-28 |
グリコミメティクス， インコーポレイテッド |
Ｅ−セレクチンおよびｃｘｃｒ４ケモカイン受容体のヘテロ二官能性阻害剤
|
|
WO2017151708A1
(en)
|
2016-03-02 |
2017-09-08 |
Glycomimetics, Inc. |
Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
|
|
US11433086B2
(en)
|
2016-08-08 |
2022-09-06 |
Glycomimetics, Inc. |
Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
|
|
AU2017341065B2
(en)
|
2016-10-07 |
2023-04-06 |
Crescent Biopharma, Inc. |
Highly potent multimeric E-selectin antagonists
|
|
EP3596096A1
(en)
|
2017-03-15 |
2020-01-22 |
GlycoMimetics, Inc. |
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
|
|
JP7275131B2
(ja)
|
2017-11-30 |
2023-05-17 |
グリコミメティクス， インコーポレイテッド |
骨髄浸潤リンパ球を動員する方法、およびその使用
|
|
KR20200104889A
(ko)
|
2017-12-29 |
2020-09-04 |
글리코미메틱스, 인크. |
E-셀렉틴 및 갈렉틴-3의 이종이기능성 억제제
|
|
KR20200128025A
(ko)
|
2018-03-05 |
2020-11-11 |
글리코미메틱스, 인크. |
급성 골수성 백혈병 및 관련 병태의 치료 방법
|
|
US11845771B2
(en)
|
2018-12-27 |
2023-12-19 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of E-selectin and galectin-3
|
|
US20230263832A1
(en)
*
|
2020-07-10 |
2023-08-24 |
Children's Medical Center Corporation |
Targeted drug delivery to sites of intravascular occlusion
|